Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)
Others
Ratios

BioLineRx (BLRX) EPS (Basic) (2023 - 2025)

Historic EPS (Basic) for BioLineRx (BLRX) over the last 1 years, with Q3 2023 value amounting to -$0.02.

  • BioLineRx's EPS (Basic) changed N/A to -$0.02 in Q3 2023 from the same period last year, while for Sep 2024 it was -$0.02, marking a year-over-year change of. This contributed to the annual value of -$0.03 for FY2022, which is 2500.0% up from last year.
  • BioLineRx's EPS (Basic) amounted to -$0.02 in Q3 2023.
  • BioLineRx's 5-year EPS (Basic) high stood at $0.02 for Q2 2023, and its period low was -$0.02 during Q3 2023.